PedAM
Pediatric Disease Annotations & Medicines
| Disease | interstitial lung disease |
| Phenotype | C0020542|pulmonary hypertension |
| Sentences | 21 |
| PubMedID- 26283756 | B-lines in assessment of pulmonary hypertension in patients with interstitial lung diseases: feasibility of transthoracic lung sonographic signs. |
| PubMedID- 21536179 | [pulmonary hypertension in interstitial lung diseases: diagnostic and therapeutic approach in 2011. |
| PubMedID- 22425136 | pulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk test. |
| PubMedID- 21454061 | Conclusion: severe kco reduction is frequently related to pulmonary hypertension, especially when associated with emphysema and/or interstitial lung disease. |
| PubMedID- 23797369 | We tested whether sscpah or systemic sclerosis-related pulmonary hypertension with interstitial lung disease imposes a greater pulmonary vascular load than ipah and leads to worse rv contractile function. |
| PubMedID- 21613438 | Purpose: to study the reliability of pulmonary vascular measurements based on computed tomography (ct) in the prediction of pulmonary hypertension (ph) in patients with advanced interstitial lung disease (ild) compared with those without ild. |
| PubMedID- 25613108 | Role of bnp and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: an algorithm application model. |
| PubMedID- 20920139 | The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease. |
| PubMedID- 23543646 | Treatment of pulmonary hypertension in interstitial lung disease: do not throw out the baby with the bath water. |
| PubMedID- 21474572 | Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease. |
| PubMedID- 22415303 | The a2b adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease. |
| PubMedID- 21538327 | Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies. |
| PubMedID- 25183617 | We report the case of a 75-years-old man who diagnosed with severe pulmonary hypertension, associated with interstitial lung disease characterized by a rapid and fatal outcome. |
| PubMedID- 23034317 | Diagnostic and prognostic role of biomarkers for pulmonary hypertension in interstitial lung disease. |
| PubMedID- 25378843 | [25] the prevalence of isolated pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease in systemic sclerosis were similar and ranged between 18 and 22% in various studies. |
| PubMedID- 22936711 | We assessed the safety, tolerability and preliminary efficacy of riociguat, a soluble guanylate cyclase stimulator, in patients with pulmonary hypertension associated with interstitial lung disease (ph-ild). |
| PubMedID- 24697923 | Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with pde-5 inhibitors. |
| PubMedID- 22054725 | Response to pulmonary vasodilator treatment in a former smoker with combined interstitial lung disease complicated by pulmonary hypertension: case report and review of the literature. |
| PubMedID- 23271856 | We report a scd patient who presented with ct proven interstitial lung disease complicated by pulmonary hypertension and cor pulmonale. |
| PubMedID- 21846759 | Ct detection of pulmonary hypertension in interstitial lung disease: the glass is half full. |
| PubMedID- 26473476 | However, our study could not adjust for pulmonary hypertension, a complication of interstitial lung disease, including idiopathic lung fibrosis. |
Page: 1